Proteome analyses of the growth inhibitory effects of NCH-51, a novel histone deacetylase inhibitor, on lymphoid malignant cells (Q40095635)

17 September 2017

Proteome analyses of the growth inhibitory effects of NCH-51, a novel histone deacetylase inhibitor, on lymphoid malignant cells (English)

1 reference

17 September 2017

Sanda T

1

1 reference

17 September 2017

Okamoto T

2

1 reference

17 September 2017

Uchida Y

3

1 reference

17 September 2017

Nakagawa H

4

1 reference

17 September 2017

Iida S

5

1 reference

17 September 2017

Kayukawa S

6

1 reference

17 September 2017

Suzuki T

7

1 reference

17 September 2017

Oshizawa T

8

1 reference

17 September 2017

Suzuki T

9

1 reference

17 September 2017

Miyata N

10

1 reference

17 September 2017

Ueda R

11

1 reference

17 September 2017

9 August 2007

1 reference

17 September 2017

1 reference

17 September 2017

21

1 reference

17 September 2017

11

1 reference

17 September 2017

2344-2353

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404902

17 September 2017

0 references

cites work

Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404902

7 January 2021

The language of covalent histone modifications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404902

7 January 2021

Cellular memory and the histone code

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404902

7 January 2021

Epigenetic targets in hematopoietic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404902

7 January 2021

Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404902

7 January 2021

Global histone modification patterns predict risk of prostate cancer recurrence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404902

7 January 2021

Drug insight: Histone deacetylase inhibitors--development of the new targeted anticancer agent suberoylanilide hydroxamic acid

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404902

7 January 2021

Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404902

7 January 2021

Phase I and pharmacokinetic study of MS-275, a histone deacetylase inhibitor, in patients with advanced and refractory solid tumors or lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404902

7 January 2021

Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404902

7 January 2021

Novel inhibitors of human histone deacetylases: design, synthesis, enzyme inhibition, and cancer cell growth inhibition of SAHA-based non-hydroxamates.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404902

7 January 2021

Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404902

7 January 2021

Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404902

7 January 2021

Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404902

7 January 2021

HDAC6 is a microtubule-associated deacetylase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404902

7 January 2021

Impairment of p53 acetylation, stability and function by an oncogenic transcription factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404902

7 January 2021

Duration of nuclear NF-kappaB action regulated by reversible acetylation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404902

7 January 2021

Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404902

7 January 2021

Induction of cell death in adult T-cell leukemia cells by a novel IkappaB kinase inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404902

7 January 2021

Multiple myeloma oncogene 1 (MUM1)/interferon regulatory factor 4 (IRF4) upregulates monokine induced by interferon-gamma (MIG) gene expression in B-cell malignancy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404902

7 January 2021

CYTOLOGY OF BURKITT'S TUMOUR (AFRICAN LYMPHOMA)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404902

7 January 2021

ARK5 is transcriptionally regulated by the Large-MAF family and mediates IGF-1-induced cell invasion in multiple myeloma: ARK5 as a new molecular determinant of malignant multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404902

7 January 2021

Growth inhibition of multiple myeloma cells by a novel IkappaB kinase inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404902

7 January 2021

Induction of OGG1 gene expression by HIV-1 Tat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404902

7 January 2021

Apoptosis in the development and maintenance of the immune system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404902

7 January 2021

The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404902

7 January 2021

Oxidative modification of nucleoside diphosphate kinase and its identification by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404902

7 January 2021

Nm23-M2/NDP kinase B induces endogenous c-myc and nm23-M1/NDP kinase A overexpression in BAF3 cells. Both NDP kinases protect the cells from oxidative stress-induced death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404902

7 January 2021

Crystal structure of a soluble form of the intracellular chloride ion channel CLIC1 (NCC27) at 1.4-A resolution

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404902

7 January 2021

A role of reactive oxygen species in apoptotic activation of volume-sensitive Cl(-) channel

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404902

7 January 2021

The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404902

7 January 2021

Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404902

7 January 2021

Phosphorylation of elongation factor 2 by EF-2 kinase affects rate of translation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404902

7 January 2021

Cellular stresses profoundly inhibit protein synthesis and modulate the states of phosphorylation of multiple translation factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404902

7 January 2021

Pathways of chaperone-mediated protein folding in the cytosol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404902

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2404902

1 reference

Dimensions Publication ID

17 September 2017

0 references

1 reference